Patents Assigned to Instituto Nacional de Neurologia y Neurocirurgia Manuel Velasco Suarez
  • Patent number: 8268893
    Abstract: The use of dapsone is the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90% in the adverse effects which occur as a consequence of the infarction.
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: September 18, 2012
    Assignees: Universidad Autonoma Metropolitana, Instituto Nacional de Neurologia y Neurocirurgia Manuel Velasco Suarez
    Inventors: Luis Camílo Ríos Castañeda, Marina Altagracia Martínez, Juan Nader Kawachi, Jaime Kravzov Jinich
  • Publication number: 20100063159
    Abstract: The use of dapsone is the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90% in the adverse effects which occur as a consequence of the infarction.
    Type: Application
    Filed: March 16, 2004
    Publication date: March 11, 2010
    Applicants: UNIVERSIDAD AUTÓNOMA METROPOLITANA, INSTITUTO NACIONAL DE NEUROLOGIA Y NEUROCIRURGIA MANUEL VELASCO SUAREZ
    Inventors: Luis Camílo Ríos Castañeda, Marina Altagracia Martínez, Juan Nader Kawachi, Jaime Kravzov Jinich